William Damsky

Credentials: · · · · ·

History

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma
Nature Genetics · 2009 · 953 citations
JAK inhibitors in dermatology: The promise of a new drug class
Review · Journal of the American Academy of Dermatology · 2017 · First of 2 authors · 395 citations
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
Nature · 2020 · Co-first of 13 authors · 313 citations

Delineation of the Immunobiology of Sarcoidosis and Characterization of the Effects of Janus Kinase Inhibition
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $861.3K · Yale University
2021–2026

Tyrosine Kinase 2 (TYK2) for GA and CS
Principal investigator · Withdrawn · Phase 2
Yale University
2025–2026
Janus Kinase Inhibition in Granuloma Annulare
Principal investigator · Active not recruiting · Phase 2
William Damsky
2023–2025
Janus Kinase Inhibition in Sarcoidosis
Principal investigator · Completed · Phase 2
Yale University
2023–2025
Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare
Principal investigator · Completed · Phase 1
TWi Biotechnology, Inc.
2022–2023